In a complementary in vitro model, SPTAN1 knockdown strains of three widely used colon cancer cell lines were less responsive to FOLFOX chemotherapy compared with SPTAN1-proficient control strains. The gene discussed is SPTAN1; the disease is colonic neoplasm.